B
Biofrontera D
D
BFRI
1.32000
USD
0.08
(6.02%)
مغلق
حجم التداول
6,230
الربح لكل سهم
-1
العائد الربحي
-
P/E
-3
حجم السوق
19,605,114
المقالات
العنوان: Biofrontera
القطاع: الرعاية الصحية
الصناعة: Drug Manufacturers - Specialty & Generic
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products,which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.

